These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6801103)

  • 21. Gargoylism (mucopolysaccharidosis type II). Accumulation of glycosaminoglycans, gangliosides and glycoproteins and activity of some related glycolytic enzymes in liver, spleen and brain.
    Roukema PA; Oderkerk CH; van den Berg G
    Clin Chim Acta; 1973 Mar; 44(3):277-86. PubMed ID: 4266536
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical presentation and diagnosis of mucopolysaccharidosis type 2 (Hunter syndrome).
    Patil R; Wasekar N; Jadhav SG; Zore R; Sangoi P; Vishwanathan D
    J Assoc Physicians India; 2013 Aug; 61(8):574-6. PubMed ID: 24818348
    [No Abstract]   [Full Text] [Related]  

  • 23. [Biochemical differentiation of Hurler's and Hunter's diseases by fracionation of heparitin sulfate].
    Maroteaux P
    Rev Eur Etud Clin Biol; 1970 Feb; 15(2):203-5. PubMed ID: 4245695
    [No Abstract]   [Full Text] [Related]  

  • 24. Prenatal monitoring for the Hunter syndrome: the heterozygous female fetus.
    Kleijer WJ; Moody PD; Liebaers I; van de Kamp JJ; Niermeijer MF
    Clin Genet; 1979 Feb; 15(2):113-7. PubMed ID: 153809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical definition of the mucopolysaccharidoses.
    Constantopoulos G; Dekaban AS
    Clin Chim Acta; 1975 Mar; 59(3):321-36. PubMed ID: 123832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucolipidosis II (I-cell disease): ultrastructural observations of conjunctiva and skin.
    Kenyon KR; Sensenbrenner JA
    Invest Ophthalmol; 1971 Aug; 10(8):555-67. PubMed ID: 4255137
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on the composition of urinary glycosaminoglycans and oligosaccharides in patients with mucopolysaccharidoses who were receiving fibroblast transplants.
    Purkiss P; Gibbs DA; Watts RW
    Clin Chim Acta; 1983 Jun; 131(1-2):109-21. PubMed ID: 6411385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemistry of heparitin sulfate and heparin from normal tissues and from patients with Hunter syndrome.
    Nader HB; Cohen DM; Dietrich CP
    Biochim Biophys Acta; 1979 Jan; 582(1):33-43. PubMed ID: 153768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of enzyme replacement therapy with idursulfase beta in children aged younger than 6 years with Hunter syndrome.
    Sohn YB; Cho SY; Lee J; Kwun Y; Huh R; Jin DK
    Mol Genet Metab; 2015 Feb; 114(2):156-60. PubMed ID: 25219292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical, biochemical and molecular characteristics of Filipino patients with mucopolysaccharidosis type II - Hunter syndrome.
    Chiong MA; Canson DM; Abacan MA; Baluyot MM; Cordero CP; Silao CL
    Orphanet J Rare Dis; 2017 Jan; 12(1):7. PubMed ID: 28077157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hunter syndrome presenting as macrocephaly and hydrocephalus.
    Yatziv S; Epstein CJ
    J Med Genet; 1977 Dec; 14(6):445-7. PubMed ID: 146740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acid mucopolysaccharides in the cerebrospinal fluid of patients with Hunter-Hurler's syndrome.
    Constantopoulos G; Dekaban AS
    J Neurochem; 1970 Jan; 17(1):117-20. PubMed ID: 4250216
    [No Abstract]   [Full Text] [Related]  

  • 33. Hunter-Hurler Syndrome: clinical and biochemical study. Combined clinical staff conference at th National Institutes of Health.
    Dekaban A; Rennert O; Hathaway B
    Med Ann Dist Columbia; 1966 Nov; 35(11):596-602. PubMed ID: 4224139
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical definition of the Hurler-Hunter phenotypes. A review of 50 patients.
    Leroy JG; Crocker AC
    Am J Dis Child; 1966 Dec; 112(6):518-30. PubMed ID: 4224657
    [No Abstract]   [Full Text] [Related]  

  • 35. Hunter-Hurler syndrome: gel filtration and dialysis of urinary acid mucopolysaccharides.
    Constantopoulos G
    Nature; 1968 Nov; 220(5167):583-5. PubMed ID: 4234914
    [No Abstract]   [Full Text] [Related]  

  • 36. Characterization of the factor deficient in the Hunter syndrome by polyacrylamide gel electrophoresis.
    Cantz M; Chrambach A; Neufeld EF
    Biochem Biophys Res Commun; 1970 Jun; 39(5):936-42. PubMed ID: 4987382
    [No Abstract]   [Full Text] [Related]  

  • 37. [Mucopolysaccharidoses. II. Biochemical study of mucopolysaccharidoses].
    Calatroni A
    Minerva Pediatr; 1972 Oct; 24(34):1579-98. PubMed ID: 4264141
    [No Abstract]   [Full Text] [Related]  

  • 38. Oxidative and nitrative stress and pro-inflammatory cytokines in Mucopolysaccharidosis type II patients: effect of long-term enzyme replacement therapy and relation with glycosaminoglycan accumulation.
    Jacques CE; Donida B; Mescka CP; Rodrigues DG; Marchetti DP; Bitencourt FH; Burin MG; de Souza CF; Giugliani R; Vargas CR
    Biochim Biophys Acta; 2016 Sep; 1862(9):1608-16. PubMed ID: 27251652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Idursulfase enzyme replacement therapy in an adult patient with severe Hunter syndrome having a novel mutation of iduronate-2-sulfatase gene.
    Christianto A; Watanabe H; Nakajima T; Inazu T
    Clin Chim Acta; 2013 Aug; 423():66-8. PubMed ID: 23726270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Normal excretion of urinary acid mucopolysaccharides in a boy with iduronate sulphatase deficiency, Hunter phenotype and alpha 1-antitrypsin deficiency.
    Nielsen JB; Güttler F; Hobolth N; Tønnesen T; Pedersen OD; Lykkelund C; Rosleff F
    Eur J Pediatr; 1986 Dec; 145(6):572-5. PubMed ID: 2949978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.